Literature DB >> 30390750

Management of Ventilator-Associated Pneumonia: Guidelines.

Mark L Metersky1, Andre C Kalil2.   

Abstract

Two recent major guidelines on diagnosis and treatment of ventilator-associated pneumonia (VAP) recommend consideration of local antibiotic resistance patterns and individual patient risks for resistant pathogens when formulating an initial empiric antibiotic regimen. One recommends against invasive diagnostic techniques with quantitative cultures to determine the cause of VAP; the other recommends either invasive or noninvasive techniques. Both guidelines recommend short-course therapy be used for most patients with VAP. Although neither guideline recommends use of procalcitonin as an adjunct to clinical judgment when diagnosing VAP, they differ with respect to use of serial procalcitonin to shorten the length of antibiotic treatment.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Guideline; Hospital-acquired pneumonia; Nosocomial pneumonia; Ventilator-associated pneumonia

Mesh:

Substances:

Year:  2018        PMID: 30390750     DOI: 10.1016/j.ccm.2018.08.002

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  5 in total

Review 1.  Do probiotics help prevent ventilator-associated pneumonia in critically ill patients? A systematic review with meta-analysis.

Authors:  Jie Zhao; Lei-Qing Li; Cheng-Yang Chen; Gen-Sheng Zhang; Wei Cui; Bao-Ping Tian
Journal:  ERJ Open Res       Date:  2021-01-25

2.  Clinical Efficacy and In Vitro Drug Sensitivity Test Results of Azithromycin Combined With Other Antimicrobial Therapies in the Treatment of MDR P. aeruginosa Ventilator-Associated Pneumonia.

Authors:  Yuqin Huang; Wenguo Wang; Qiang Huang; Zhengyan Wang; Zhuanzhuan Xu; Chaochao Tu; Dongli Wan; Miaobo He; Xiaoyi Yang; Huaqiang Xu; Hanqin Wang; Ying Zhao; Mingli Tu; Quan Zhou
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

3.  Thiamine May Be Beneficial for Patients With Ventilator-Associated Pneumonia in the Intensive Care Unit: A Retrospective Study Based on the MIMIC-IV Database.

Authors:  Luming Zhang; Shaojin Li; Xuehao Lu; Yu Liu; Yinlong Ren; Tao Huang; Jun Lyu; Haiyan Yin
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

4.  Multi-Drug Resistant Organisms Infection Impact on Patients Length of Stay in Respiratory Care Ward.

Authors:  Yi-Ping Chen; Xian-Wen Tasi; Ko Chang; Xuan-Di Cao; Jung-Ren Chen; Chien-Sen Liao
Journal:  Antibiotics (Basel)       Date:  2021-05-20

Review 5.  The Gut Microbiota and Respiratory Diseases: New Evidence.

Authors:  Li Chunxi; Liu Haiyue; Lin Yanxia; Pan Jianbing; Su Jin
Journal:  J Immunol Res       Date:  2020-07-31       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.